U.S. Markets closed

Vycor Medical, Inc. (VYCO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.14800.0000 (0.00%)
At close: 9:34AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1260
Open0.1220
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1200 - 0.1500
52 Week Range0.0250 - 0.4780
Volume11,200
Avg. Volume17,166
Market Cap4.129M
Beta (5Y Monthly)2.40
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Vycor Medical, Inc. Agrees New NovaVision Licensing Agreement

    Vycor Medical, Inc. (“Vycor”) (OTCBB—VYCO) today announced that its wholly owned subsidiary, NovaVision, Inc. (“NovaVision”), has signed an agreement in principle to enter into an exclusive licensing agreement with HelferApp GmbH (“HelferApp”). Under the terms of the agreement HelferApp will have the exclusive rights for NovaVision’s diagnostic products and therapies provided direct to the patient and to medical professionals in Germany, Austria and Switzerland. The combination of the NovaVision therapies will allow HelferApp to create an unrivalled portfolio of scientifically supported therapies addressing the visual rehabilitation market in the territories.